AdaptHealth Future Growth
Future criteria checks 4/6
AdaptHealth is forecast to grow earnings and revenue by 107.1% and 7.2% per annum respectively. EPS is expected to grow by 102% per annum. Return on equity is forecast to be 7.1% in 3 years.
Key information
107.1%
Earnings growth rate
102.0%
EPS growth rate
Healthcare earnings growth | 28.1% |
Revenue growth rate | 7.2% |
Future return on equity | 7.1% |
Analyst coverage | Good |
Last updated | 29 Jan 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 4,472 | 85 | N/A | N/A | 1 |
12/31/2025 | 3,605 | 121 | 156 | 519 | 8 |
12/31/2024 | 3,345 | 91 | 119 | 461 | 10 |
12/31/2023 | 3,167 | -405 | 93 | 431 | 10 |
9/30/2023 | 3,122 | -427 | 31 | 422 | N/A |
6/30/2023 | 3,075 | 42 | 22 | 431 | N/A |
3/31/2023 | 3,009 | 40 | 44 | 448 | N/A |
12/31/2022 | 2,971 | 63 | -18 | 374 | N/A |
9/30/2022 | 2,903 | 87 | 66 | 378 | N/A |
6/30/2022 | 2,800 | 125 | 20 | 298 | N/A |
3/31/2022 | 2,689 | 184 | 79 | 324 | N/A |
12/31/2021 | 2,465 | 142 | 72 | 276 | N/A |
9/30/2021 | 2,115 | 40 | 68 | 225 | N/A |
6/30/2021 | 1,746 | -64 | 124 | 232 | N/A |
3/31/2021 | 1,361 | -131 | 122 | 190 | N/A |
12/31/2020 | 1,071 | -162 | 156 | 196 | N/A |
9/30/2020 | 858 | -91 | 133 | 163 | N/A |
6/30/2020 | 710 | -44 | 124 | 145 | N/A |
3/31/2020 | 602 | -50 | 45 | 69 | N/A |
12/31/2019 | 530 | -21 | 39 | 60 | N/A |
9/30/2019 | 489 | -8 | 52 | 68 | N/A |
6/30/2019 | 454 | 8 | 57 | 72 | N/A |
3/31/2019 | 398 | 14 | 61 | 73 | N/A |
12/31/2018 | 345 | 23 | 58 | 68 | N/A |
12/31/2017 | 193 | 10 | 39 | 46 | N/A |
12/31/2016 | 174 | -4 | N/A | 30 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: A2HC34 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (9.7%).
Earnings vs Market: A2HC34 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: A2HC34 is expected to become profitable in the next 3 years.
Revenue vs Market: A2HC34's revenue (7.2% per year) is forecast to grow faster than the BR market (6.4% per year).
High Growth Revenue: A2HC34's revenue (7.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: A2HC34's Return on Equity is forecast to be low in 3 years time (7.1%).